Connect with us

Pharma & Healthcare

New Report Brews Up End Stage Renal Disease Market



Market Definition

The Global End Stage Renal Disease market is estimated at $ 65 billion in 2019, and expected to reach $ 172.80 billion by 2027, with a CAGR of 13% from 2020 to 2027.

End stage renal disease is a state in which chronic kidney disease reaches an advances state, where kidneys are not able to work normally.

Request sample copy at

Market Dynamics

The Global End Stage Renal Disease market is primarily driven by factors such as the growing occurrences of kidney diseases and kidney failure; technological innovation in the kidney related products; growing geriatric population; growing occurrences of diabetes, hypertension and other diseases having renal complication; growing focus on research and developments; are some of the market dynamics.

Market Segmentation

The Global End Stage Renal Disease Market is mainly classified based on Treatment, End User, and Region.

  • Based on Treatment, the market is further segmented into Renal Dialysis (Hemodialysis, Peritoneal Dialysis, Wearable Artificial Kidney) and Renal Transplantation
  • Based on End User, the market is further segmented into Dialysis Centers, Research and Academic Institutes, Hospitals & Clinics, and Other Users

Inquire for a Discount at

Regional Analysis

Based on geography, the Global End Stage Renal Disease market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape                     

Global End Stage Renal Disease Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global End Stage Renal Disease sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2019-2027, this study provides the Global End Stage Renal Disease sales, revenue and market share for each player covered in this report.


The major players covered in Global End Stage Renal Disease are Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Medtronic Plc, Fresenius Medical Care AG & Co., Baxter International Inc., JMS Co. Ltd., Becton (Dickinson and Company), Nikkiso Co. Ltd., Cantel Medical, and other prominent players.

End Stage Renal Disease Market Key Segments:

By Treatment

  • Renal Dialysis
    • Hemodialysis
    • Peritoneal Dialysis
    • Wearable Artificial Kidney
  • Renal Transplantation

By End User

  • Hospitals & Clinics
  • Dialysis Centers
  • Research and Academic Institutes
  • Other Users

By Region             

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent News